
Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) – Stock analysts at B. Riley decreased their Q2 2026 EPS estimates for Tactile Systems Technology in a report released on Monday, November 3rd. B. Riley analyst A. Schock now expects that the company will post earnings per share of $0.23 for the quarter, down from their previous forecast of $0.25. B. Riley currently has a “Neutral” rating and a $13.00 target price on the stock. The consensus estimate for Tactile Systems Technology’s current full-year earnings is $0.70 per share. B. Riley also issued estimates for Tactile Systems Technology’s Q4 2026 earnings at $0.52 EPS and FY2026 earnings at $1.06 EPS.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.16 by $0.20. The company had revenue of $85.76 million during the quarter, compared to analysts’ expectations of $79.31 million. Tactile Systems Technology had a net margin of 5.06% and a return on equity of 7.72%. Tactile Systems Technology has set its FY 2025 guidance at EPS.
Get Our Latest Analysis on TCMD
Tactile Systems Technology Price Performance
Shares of NASDAQ:TCMD opened at $22.18 on Wednesday. The company has a 50 day moving average of $14.36 and a 200 day moving average of $12.15. The stock has a market cap of $494.44 million, a P/E ratio of 35.77 and a beta of 1.04. Tactile Systems Technology has a 12 month low of $8.61 and a 12 month high of $23.84. The company has a current ratio of 3.79, a quick ratio of 3.36 and a debt-to-equity ratio of 0.11.
Institutional Investors Weigh In On Tactile Systems Technology
A number of large investors have recently modified their holdings of the business. Dynamic Technology Lab Private Ltd purchased a new position in shares of Tactile Systems Technology in the 1st quarter valued at approximately $534,000. Victory Capital Management Inc. acquired a new position in Tactile Systems Technology during the 1st quarter valued at approximately $1,160,000. Acadian Asset Management LLC raised its holdings in shares of Tactile Systems Technology by 149.1% in the first quarter. Acadian Asset Management LLC now owns 196,270 shares of the company’s stock worth $2,594,000 after buying an additional 117,480 shares during the last quarter. Punch & Associates Investment Management Inc. raised its holdings in shares of Tactile Systems Technology by 34.3% in the first quarter. Punch & Associates Investment Management Inc. now owns 282,000 shares of the company’s stock worth $3,728,000 after buying an additional 72,000 shares during the last quarter. Finally, Pinnacle Associates Ltd. lifted its stake in shares of Tactile Systems Technology by 5.5% during the second quarter. Pinnacle Associates Ltd. now owns 340,374 shares of the company’s stock worth $3,451,000 after buying an additional 17,850 shares during the period. Hedge funds and other institutional investors own 83.43% of the company’s stock.
Insider Transactions at Tactile Systems Technology
In other news, CEO Sheri Louise Dodd sold 7,762 shares of the company’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $12.36, for a total transaction of $95,938.32. Following the transaction, the chief executive officer directly owned 173,479 shares of the company’s stock, valued at approximately $2,144,200.44. This represents a 4.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.50% of the company’s stock.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- 3 Dividend Kings To Consider
- 3 Reasons Tesla Could Be a $500 Stock by the End of the Month
- ESG Stocks, What Investors Should Know
- Affirm’s New York Life Deal: A Game-Changing Stamp of Approval
- What Investors Need to Know to Beat the Market
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
